Arturo Md Molina - Net Worth and Insider Trading

Arturo Md Molina Net Worth

The estimated net worth of Arturo Md Molina is at least $2 Million dollars as of 2024-05-16. Arturo Md Molina is the Chief Medical Officer of Protagonist Therapeutics Inc and owns about 48,777 shares of Protagonist Therapeutics Inc (PTGX) stock worth over $2 Million. Arturo Md Molina is also the Chief Medical Officer of Sutro Biopharma Inc and owns about 12,083 shares of Sutro Biopharma Inc (STRO) stock worth over $47,486. Details can be seen in Arturo Md Molina's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Arturo Md Molina has not made any transactions after 2023-11-15 and currently still holds the listed stock(s).

Transaction Summary of Arturo Md Molina

To

Arturo Md Molina Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Arturo Md Molina owns 3 companies in total, including Sutro Biopharma Inc (STRO) , Forma Therapeutics Holdings Inc (FMTX) , and Protagonist Therapeutics Inc (PTGX) .

Click here to see the complete history of Arturo Md Molina’s form 4 insider trades.

Insider Ownership Summary of Arturo Md Molina

Ticker Comapny Transaction Date Type of Owner
STRO Sutro Biopharma Inc 2020-05-14 Chief Medical Officer
FMTX Forma Therapeutics Holdings Inc 2022-01-12 director
PTGX Protagonist Therapeutics Inc 2023-11-15 Chief Medical Officer

Arturo Md Molina Latest Holdings Summary

Arturo Md Molina currently owns a total of 2 stocks. Among these stocks, Arturo Md Molina owns 48,777 shares of Protagonist Therapeutics Inc (PTGX) as of November 15, 2023, with a value of $2 Million and a weighting of 97%. Arturo Md Molina also owns 12,083 shares of Sutro Biopharma Inc (STRO) as of May 14, 2020, with a value of $47,486 and a weighting of 3%.

Latest Holdings of Arturo Md Molina

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PTGX Protagonist Therapeutics Inc 2023-11-15 48,777 31.47 1,535,012
STRO Sutro Biopharma Inc 2020-05-14 12,083 3.93 47,486

Holding Weightings of Arturo Md Molina


Arturo Md Molina Form 4 Trading Tracker

According to the SEC Form 4 filings, Arturo Md Molina has made a total of 1 transactions in Protagonist Therapeutics Inc (PTGX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Protagonist Therapeutics Inc is the sale of 1,848 shares on November 15, 2023, which brought Arturo Md Molina around $30,012.

According to the SEC Form 4 filings, Arturo Md Molina has made a total of 1 transactions in Sutro Biopharma Inc (STRO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sutro Biopharma Inc is the acquisition of 6,451 shares on May 14, 2020, which cost Arturo Md Molina around $49,995.

Insider Trading History of Arturo Md Molina

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Arturo Md Molina Trading Performance

GuruFocus tracks the stock performance after each of Arturo Md Molina's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arturo Md Molina is 4.79%. GuruFocus also compares Arturo Md Molina's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arturo Md Molina within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Arturo Md Molina's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Arturo Md Molina

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.96
Relative Return to S&P 500(%) 2.34

Arturo Md Molina Ownership Network

Ownership Network List of Arturo Md Molina

No Data

Ownership Network Relation of Arturo Md Molina


Arturo Md Molina Owned Company Details

What does Sutro Biopharma Inc do?

Who are the key executives at Sutro Biopharma Inc?

Arturo Md Molina is the Chief Medical Officer of Sutro Biopharma Inc. Other key executives at Sutro Biopharma Inc include Chief Port. Strat & Alnce Ofcr Nicki Vasquez , Chief Scientific Officer Hans-peter Gerber , and Chief Business Officer Brunilda Shtylla .

Sutro Biopharma Inc (STRO) Insider Trades Summary

Over the past 18 months, Arturo Md Molina made no insider transaction in Sutro Biopharma Inc (STRO). Other recent insider transactions involving Sutro Biopharma Inc (STRO) include a net sale of 27,041 shares made by Brunilda Shtylla , and a net sale of 12,185 shares made by Nicki Vasquez .

In summary, during the past 3 months, insiders sold 0 shares of Sutro Biopharma Inc (STRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 39,226 shares of Sutro Biopharma Inc (STRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 39,226 shares.

Sutro Biopharma Inc (STRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sutro Biopharma Inc Insider Transactions

No Available Data

Arturo Md Molina Mailing Address

Above is the net worth, insider trading, and ownership report for Arturo Md Molina. You might contact Arturo Md Molina via mailing address: 10990 Wilshire Blvd, Suite 1200, Los Angeles Ca 90024.

Discussions on Arturo Md Molina

No discussions yet.